ICMM Teaching

Medicine & Life Sciences

1. Narcolepsy 100%
2. Sleep 66%
3. Cataplexy 63%
4. Orexins 57%
5. Hip 53%
6. Type 2 Diabetes Mellitus 49%
7. Insulin Resistance 45%
8. REM Sleep Behavior Disorder 41%
9. Alleles 37%
10. Patient Reported Outcome Measures 35%
11. Genes 32%
12. Mortality 32%
13. Skeletal Muscle 31%
14. Exercise 31%
15. Denmark 31%
16. REM Sleep 30%
17. Pain 29%
18. Groin 29%
19. Vestibular Aqueduct 28%
20. Peripheral Nervous System Neoplasms 28%
21. Upper Extremity 27%
22. Glucose 27%
23. Obstructive Sleep Apnea 26%
24. Mutation 25%
25. Insulin 25%
26. Muscles 24%
27. Endolymphatic Sac 23%
28. procollagen type I carboxy terminal peptide 23%
29. Costs and Cost Analysis 23%
30. procollagen Type III-N-terminal peptide 22%
31. Genome-Wide Association Study 22%
32. Heterozygote 22%
33. Optic Neuritis 22%
34. Obesity 22%
35. Twins 21%
36. Therapeutics 21%
37. Collagen Type III 21%
38. Multiple Sclerosis 21%
39. Soccer 21%
40. Electrooculography 20%
41. Neoplasms 20%
42. Sleep Apnea Syndromes 20%
43. HLA-DQB1 antigen 20%
44. Conjunctiva 20%
45. Population 20%
46. 64Cu-DOTATATE 20%
47. Cytokines 19%
48. Peptides 19%
49. Congenital primary aphakia 19%
50. Heart Failure 19%
51. Wounds and Injuries 19%
52. Trichilemmal Cyst 1 18%
53. Electroencephalography 18%
54. Glutamine 18%
55. Sleep Initiation and Maintenance Disorders 18%
56. Suprachiasmatic Nucleus 18%
57. Reproducibility of Results 18%
58. Echocardiography 17%
59. Phosphatidylinositol 3-Kinase 17%
60. Sleepiness 17%
61. Three-Dimensional Echocardiography 17%
62. Health 17%
63. Collagen Type I 17%
64. Patterson Stevenson syndrome 17%
65. Insulin Secretion 17%
66. Carbohydrates 17%
67. Parkinson Disease 17%
68. ErbB Receptors 16%
69. Sleep Wake Disorders 16%
70. Epidemiologic Studies 16%
71. Magnetic Resonance Imaging 16%
72. Autoantibodies 16%
73. Confidence Intervals 16%
74. Collagen 15%
75. Neurodegenerative Diseases 15%
76. Proglucagon 15%
77. Comorbidity 15%
78. Right Ventricular Function 15%
79. Prospective Studies 15%
80. Serum 15%
81. Neurons 15%